A detailed history of Squarepoint Ops LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 43,040 shares of PACB stock, worth $83,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,040
Previous 524,608 91.8%
Holding current value
$83,928
Previous $718,000 89.83%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.2 - $2.17 $577,881 - $1.05 Million
-481,568 Reduced 91.8%
43,040 $73,000
Q2 2024

Aug 14, 2024

BUY
$1.36 - $3.65 $713,466 - $1.91 Million
524,608 New
524,608 $718,000
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $986,471 - $1.39 Million
98,944 New
98,944 $1.32 Million
Q4 2022

Feb 14, 2023

SELL
$5.67 - $11.2 $1.94 Million - $3.83 Million
-341,602 Reduced 52.36%
310,800 $2.54 Million
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $802,289 - $1.75 Million
-204,145 Reduced 23.83%
652,402 $3.79 Million
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $149,049 - $386,713
37,077 Added 4.52%
856,547 $3.79 Million
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $6.75 Million - $16.7 Million
800,175 Added 4147.06%
819,470 $7.46 Million
Q4 2021

Feb 14, 2022

SELL
$19.26 - $30.08 $6.88 Million - $10.8 Million
-357,381 Reduced 94.88%
19,295 $395,000
Q3 2021

Nov 15, 2021

BUY
$24.86 - $35.02 $8.36 Million - $11.8 Million
336,247 Added 831.7%
376,676 $9.62 Million
Q2 2021

Aug 16, 2021

BUY
$22.3 - $36.02 $154,026 - $248,790
6,907 Added 20.6%
40,429 $1.41 Million
Q1 2021

May 17, 2021

SELL
$26.38 - $51.15 $643,619 - $1.25 Million
-24,398 Reduced 42.12%
33,522 $1.12 Million
Q4 2020

Feb 16, 2021

BUY
$10.5 - $28.5 $608,160 - $1.65 Million
57,920 New
57,920 $1.5 Million
Q3 2020

Nov 16, 2020

SELL
$3.61 - $9.87 $273,042 - $746,517
-75,635 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$2.65 - $4.03 $200,432 - $304,809
75,635 New
75,635 $261,000
Q1 2020

May 15, 2020

SELL
$2.36 - $5.26 $452,591 - $1.01 Million
-191,776 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$4.6 - $5.57 $732,780 - $887,301
159,300 Added 490.52%
191,776 $986,000
Q3 2019

Nov 14, 2019

SELL
$4.99 - $6.16 $934,083 - $1.15 Million
-187,191 Reduced 85.22%
32,476 $168,000
Q2 2019

Aug 14, 2019

SELL
$5.92 - $7.41 $122,502 - $153,335
-20,693 Reduced 8.61%
219,667 $1.33 Million
Q1 2019

May 15, 2019

SELL
$6.8 - $7.4 $171,183 - $186,287
-25,174 Reduced 9.48%
240,360 $1.74 Million
Q4 2018

Feb 14, 2019

BUY
$3.99 - $7.82 $1.06 Million - $2.08 Million
265,534 New
265,534 $1.97 Million
Q1 2018

May 15, 2018

SELL
$2.05 - $3.23 $30,702 - $48,375
-14,977 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$2.59 - $5.44 $38,790 - $81,474
14,977
14,977 $40,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.